1	Comparative	comparative	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NFAT	NFAT	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	complex	complex	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	B	b	_	_	_	_	_	_	_
19	lymphocytes	lymphocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	activated	activate	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	NFAT	NFAT	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	transcriptional	transcriptional	_	_	_	_	_	_	_
13	activator	activator	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	binds	bind	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	sequences	sequence	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	interleukin-2	interleukin-2	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	promoter	promoter	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	is	be	_	_	_	_	_	_	_
27	thought	think	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	be	be	_	_	_	_	_	_	_
30	largely	largely	_	_	_	_	_	_	_
31	responsible	responsible	_	_	_	_	_	_	_
32	for	for	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	T	t	_	_	_	_	_	_	_
35	cell-specific	cell-specific	_	_	_	_	_	_	_
36	inducibility	inducibility	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	IL-2	il-2	_	_	_	_	_	_	_
39	expression	expression	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assays	assay	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	EMSA	EMSA	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	showed	show	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	specific	specific	_	_	_	_	_	_	_
11	NFAT	nfat	_	_	_	_	_	_	_
12	binding	binding	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	could	could	_	_	_	_	_	_	_
15	also	also	_	_	_	_	_	_	_
16	be	be	_	_	_	_	_	_	_
17	induced	induce	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	B	B	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	NFAT	nfat	_	_	_	_	_	_	_
5	complex	complex	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	however	however	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	functional	functional	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	since	since	_	_	_	_	_	_	_
14	it	it	_	_	_	_	_	_	_
15	failed	fail	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	activate	activate	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	NFAT-driven	nfat-driven	_	_	_	_	_	_	_
22	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
23	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	CAT	CAT	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	construct	construct	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Competition	competition	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	AP-1	ap-1	_	_	_	_	_	_	_
5	motif	motif	_	_	_	_	_	_	_
6	or	or	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	anti-Jun	anti-jun	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	anti-Fos	anti-fos	_	_	_	_	_	_	_
11	antibodies	antibody	_	_	_	_	_	_	_
12	abolished	abolish	_	_	_	_	_	_	_
13	binding	binding	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	NFAT	nfat	_	_	_	_	_	_	_
17	motif	motif	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	both	both	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	B	b	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	indicating	indicate	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	Jun	Jun	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	Fos	Fos	_	_	_	_	_	_	_
30	are	be	_	_	_	_	_	_	_
31	critical	critical	_	_	_	_	_	_	_
32	for	for	_	_	_	_	_	_	_
33	NFAT	NFAT	_	_	_	_	_	_	_
34	complex	complex	_	_	_	_	_	_	_
35	formation	formation	_	_	_	_	_	_	_
36	in	in	_	_	_	_	_	_	_
37	both	both	_	_	_	_	_	_	_
38	cell	cell	_	_	_	_	_	_	_
39	types	type	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Purified	purify	_	_	_	_	_	_	_
2	recombinant	recombinant	_	_	_	_	_	_	_
3	Jun	Jun	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	Fos	Fos	_	_	_	_	_	_	_
6	proteins	protein	_	_	_	_	_	_	_
7	failed	fail	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	bind	bind	_	_	_	_	_	_	_
10	directly	directly	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	NFAT	NFAT	_	_	_	_	_	_	_
14	motif	motif	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	when	when	_	_	_	_	_	_	_
4	combined	combine	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	unstimulated	unstimulated	_	_	_	_	_	_	_
7	B	b	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	extracts	extract	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	full-length	full-length	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	truncated	truncate	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	Jun/Fos	Jun/Fos	_	_	_	_	_	_	_
20	heterodimers	heterodimer	_	_	_	_	_	_	_
21	were	be	_	_	_	_	_	_	_
22	able	able	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	form	form	_	_	_	_	_	_	_
25	an	an	_	_	_	_	_	_	_
26	NFAT	nfat	_	_	_	_	_	_	_
27	complex	complex	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	indicating	indicate	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	presence	presence	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	constitutively	constitutively	_	_	_	_	_	_	_
35	expressed	express	_	_	_	_	_	_	_
36	nuclear	nuclear	_	_	_	_	_	_	_
37	factor(s)	factor(s)	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	B	B	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	T	t	_	_	_	_	_	_	_
42	cells	cell	_	_	_	_	_	_	_
43	necessary	necessary	_	_	_	_	_	_	_
44	for	for	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	formation	formation	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	the	the	_	_	_	_	_	_	_
49	NFAT	NFAT	_	_	_	_	_	_	_
50	complex	complex	_	_	_	_	_	_	_
51	in	in	_	_	_	_	_	_	_
52	both	both	_	_	_	_	_	_	_
53	cell	cell	_	_	_	_	_	_	_
54	types	type	_	_	_	_	_	_	_
55	.	.	_	_	_	_	_	_	_

1	An	an	_	_	_	_	_	_	_
2	NFAT	NFAT	_	_	_	_	_	_	_
3	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
4	carrying	carry	_	_	_	_	_	_	_
5	mutations	mutation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	5	5	_	_	_	_	_	_	_
9	â€™	'	_	_	_	_	_	_	_
10	purine-rich	purine-rich	_	_	_	_	_	_	_
11	part	part	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	NFAT	NFAT	_	_	_	_	_	_	_
15	sequence	sequence	_	_	_	_	_	_	_
16	failed	fail	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	form	form	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	complex	complex	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	compete	compete	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	wild	wild	_	_	_	_	_	_	_
27	type	type	_	_	_	_	_	_	_
28	motif	motif	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	NFAT	NFAT	_	_	_	_	_	_	_
31	complex	complex	_	_	_	_	_	_	_
32	formation	formation	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	both	both	_	_	_	_	_	_	_
35	T	t	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	B	b	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	therefore	therefore	_	_	_	_	_	_	_
3	propose	propose	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	model	model	_	_	_	_	_	_	_
6	whereby	whereby	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	core	core	_	_	_	_	_	_	_
9	NFAT	nfat	_	_	_	_	_	_	_
10	complex	complex	_	_	_	_	_	_	_
11	consisting	consist	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	Jun	Jun	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	Fos	Fos	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	constitutive	constitutive	_	_	_	_	_	_	_
20	nuclear	nuclear	_	_	_	_	_	_	_
21	factor	factor	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	formed	form	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	both	both	_	_	_	_	_	_	_
26	T	t	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	B	b	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	but	but	_	_	_	_	_	_	_
32	an	an	_	_	_	_	_	_	_
33	additional	additional	_	_	_	_	_	_	_
34	factor	factor	_	_	_	_	_	_	_
35	and/or	and/or	_	_	_	_	_	_	_
36	post-translational	post-translational	_	_	_	_	_	_	_
37	modification	modification	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	a	a	_	_	_	_	_	_	_
40	factor	factor	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	missing	miss	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	B	B	_	_	_	_	_	_	_
45	cells	cell	_	_	_	_	_	_	_
46	,	,	_	_	_	_	_	_	_
47	might	might	_	_	_	_	_	_	_
48	be	be	_	_	_	_	_	_	_
49	required	require	_	_	_	_	_	_	_
50	for	for	_	_	_	_	_	_	_
51	transactivation	transactivation	_	_	_	_	_	_	_
52	by	by	_	_	_	_	_	_	_
53	NFAT	NFAT	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

